- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Left Main Coronary Artery Calcium and Diabetes Confer Very-High-Risk Equivalence in CAC more than 1,000: Study
USA: Among asymptomatic patients with coronary artery calcium (CAC) score > 1,000, those with severe calcium in the left main coronary artery and diabetes have more than a sevenfold greater risk of death from atherosclerotic cardiovascular disease (ASCVD) versus those who have a high CAC score alone, a recent study has shown.
Not all patients with very high levels of CAC are created equal when it comes to CV risk, with the research published in JACC: Cardiovascular Imaging providing some clues on how to identify a particularly high-risk patient who could benefit from aggressive primary prevention strategies across several domains, including low-density lipoprotein-cholesterol lowering.
Although coronary artery calcium of ≥1,000 is a subclinical atherosclerosis threshold to consider combination lipid-lowering therapy, differentiating very high from high ASCVD risk in this patient population is not well-defined. Therefore, Alexander C. Razavi, Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, Georgia, USA, and colleagues aimed to identify risk factors equating with very high-risk ASCVD mortality rates among people with a CAC of ≥1,000.
For this purpose, the researchers studied 2,246 asymptomatic patients with a CAC of ≥1,000 from the CAC Consortium without a prior ASCVD event. The mean age was 66.6 years; 14% were female, and 10% were non-White. During a median follow-up of 11.3 years, Cox proportional hazards regression modelling was performed for ASCVD mortality.
Crude ASCVD mortality rates were compared with those reported for secondary prevention trial patients classified as very high risk, defined by ≥2 major ASCVD events or 1 major event and ≥2 high-risk conditions (1.4 per 100 person-years).
The study led to the following findings:
- The median CAC score was 1,592, and 6% had severe left main (LM) CAC (vessel-specific CAC ≥300).
- Diabetes (HR: 2.04) and severe LM CAC (HR: 2.32) were associated with ASCVD mortality.
- The ASCVD mortality per 100 person-years for all patients was 0.8, although higher rates were observed for diabetes (1.4), severe LM CAC (1.3), and both diabetes and severe LM CAC (7.1).
"Among asymptomatic patients with a CAC of ≥1,000 without a prior index event, diabetes, and severe LM CAC define very high-risk atherosclerotic cardiovascular disease, identifying individuals who may benefit from more intensive prevention therapies across several domains, including LDL-cholesterol lowering," the researchers wrote.
Reference:
Razavi AC, Shaw LJ, Berman DS, Budoff MJ, Wong ND, Vaccarino V, van Assen M, De Cecco CN, Quyyumi AA, Mehta A, Muntner P, Miedema MD, Rozanski A, Rumberger JA, Nasir K, Blumenthal RS, Sperling LS, Mortensen MB, Whelton SP, Blaha MJ, Dzaye O. Left Main Coronary Artery Calcium and Diabetes Confer Very-High-Risk Equivalence in Coronary Artery Calcium >1,000. JACC Cardiovasc Imaging. 2024 Feb 12:S1936-878X(24)00026-3. doi: 10.1016/j.jcmg.2023.12.006. Epub ahead of print. PMID: 38385932.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751